Atlas Trials

Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus

Clinical trial NCT02455089 · COMPLETED

Trial details

NCT number
NCT02455089
Sponsor
University Hospital, Grenoble
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lupus Erythematosus
Start date
2015-06-01
Primary completion
2018-02-01
Enrollment
143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.